Key result
Percutaneous transcatheter implantation of pulmonary and aortic valves is an emerging technique that requires long-term follow-up to establish valve durability and freedom from re-intervention.
Percutaneous transcatheter intervention for pulmonary and aortic valves represents a new therapeutic horizon, though long-term follow-up is needed to assess durability.
Answers are grounded in this paper and cite their sources.
Early percutaneous semilunar valve interventions may extend to atrioventricular valves; leaves open feasibility and adoption pending higher-level evidence.
Percutaneous transcatheter intervention for valvular heart disease is the new horizon in transcatheter therapeutics. Balloon dilatation has been used successfully for treatment of congenital and acquired stenotic lesions of semilunar and atrio-ventricular valves. Although attempts have been made to repair and replace cardiac valves without cardiopulmonary bypass and through percutaneous techniques, this has only recently become a reality. The semilunar valves have preceded atrioventricular valves in successful application in animals and humans. Morphological features play an important role in determining the design of the valve and technique and site of implantation. The major deviations in research and development in artificial or tissue valves have included attempts at delivery of these valves to the site of implantation without open heart surgery. Successful implantation needs long-term follow-up for the durability of the valve and freedom from re-intervention.
No takes yet. Share an insight, caveat, or question.
Khambadkone et al. (2007) conducted a review in Valvular heart disease. Percutaneous transcatheter valve implantation was evaluated. Percutaneous transcatheter implantation of pulmonary and aortic valves is an emerging technique that requires long-term follow-up to establish valve durability and freedom from re-intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: